Cargando…
Supporting SMEs during COVID-19: The case for targeted equity injections()
We analyze the potential role of equity injections in addressing solvency risks among small and medium-sized enterprises (SMEs) after the COVID-19 crisis. Building on firm-level balance sheet projections for a sample of European economies, we simulate selected policy interventions and find that equi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Monetary fund. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316713/ https://www.ncbi.nlm.nih.gov/pubmed/35909983 http://dx.doi.org/10.1016/j.econlet.2022.110717 |
_version_ | 1784754882725543936 |
---|---|
author | Díez, Federico J. Duval, Romain Maggi, Chiara |
author_facet | Díez, Federico J. Duval, Romain Maggi, Chiara |
author_sort | Díez, Federico J. |
collection | PubMed |
description | We analyze the potential role of equity injections in addressing solvency risks among small and medium-sized enterprises (SMEs) after the COVID-19 crisis. Building on firm-level balance sheet projections for a sample of European economies, we simulate selected policy interventions and find that equity injections are quite effective at dampening the rise in insolvencies. Cost effectiveness requires careful targeting, however; under an illustrative scenario, leaving aside any costs arising from imperfect information and implementation, the cost of a program targeting only those SMEs worth saving is just a tenth of the cost of an untargeted approach directed to all insolvent firms. Overall, our paper provides a case for governments to rely more on targeted equity injections in responding to major shocks that trigger mass solvency risks. |
format | Online Article Text |
id | pubmed-9316713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | International Monetary fund. Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93167132022-07-26 Supporting SMEs during COVID-19: The case for targeted equity injections() Díez, Federico J. Duval, Romain Maggi, Chiara Econ Lett Article We analyze the potential role of equity injections in addressing solvency risks among small and medium-sized enterprises (SMEs) after the COVID-19 crisis. Building on firm-level balance sheet projections for a sample of European economies, we simulate selected policy interventions and find that equity injections are quite effective at dampening the rise in insolvencies. Cost effectiveness requires careful targeting, however; under an illustrative scenario, leaving aside any costs arising from imperfect information and implementation, the cost of a program targeting only those SMEs worth saving is just a tenth of the cost of an untargeted approach directed to all insolvent firms. Overall, our paper provides a case for governments to rely more on targeted equity injections in responding to major shocks that trigger mass solvency risks. International Monetary fund. Published by Elsevier B.V. 2022-10 2022-07-26 /pmc/articles/PMC9316713/ /pubmed/35909983 http://dx.doi.org/10.1016/j.econlet.2022.110717 Text en © 2022 International Monetary fund Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Díez, Federico J. Duval, Romain Maggi, Chiara Supporting SMEs during COVID-19: The case for targeted equity injections() |
title | Supporting SMEs during COVID-19: The case for targeted equity injections() |
title_full | Supporting SMEs during COVID-19: The case for targeted equity injections() |
title_fullStr | Supporting SMEs during COVID-19: The case for targeted equity injections() |
title_full_unstemmed | Supporting SMEs during COVID-19: The case for targeted equity injections() |
title_short | Supporting SMEs during COVID-19: The case for targeted equity injections() |
title_sort | supporting smes during covid-19: the case for targeted equity injections() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316713/ https://www.ncbi.nlm.nih.gov/pubmed/35909983 http://dx.doi.org/10.1016/j.econlet.2022.110717 |
work_keys_str_mv | AT diezfedericoj supportingsmesduringcovid19thecasefortargetedequityinjections AT duvalromain supportingsmesduringcovid19thecasefortargetedequityinjections AT maggichiara supportingsmesduringcovid19thecasefortargetedequityinjections |